Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia.
Lönnerholm G, Thörn I, Sundström C, Frost BM, Abrahamsson J, Behrendtz M, Heldrup J, Jacobsson S, Li A, Olofsson T, Porwit A, Söderhäll S, Larsson R, Forestier E. Lönnerholm G, et al. Among authors: li a. Leuk Res. 2009 Jan;33(1):46-53. doi: 10.1016/j.leukres.2008.06.012. Epub 2008 Jul 17. Leuk Res. 2009. PMID: 18639340
Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006.
Thörn I, Forestier E, Thuresson B, Wasslavik C, Malec M, Li A, Lindström-Eriksson E, Botling J, Barbany G, Jacobsson S, Olofsson T, Porwit A, Sundström C, Rosenquist R. Thörn I, et al. Among authors: li a. Eur J Haematol. 2010 Feb 1;84(2):117-27. doi: 10.1111/j.1600-0609.2009.01374.x. Epub 2009 Nov 6. Eur J Haematol. 2010. PMID: 19895569
Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
Thörn I, Forestier E, Botling J, Thuresson B, Wasslavik C, Björklund E, Li A, Lindström-Eriksson E, Malec M, Grönlund E, Torikka K, Heldrup J, Abrahamsson J, Behrendtz M, Söderhäll S, Jacobsson S, Olofsson T, Porwit A, Lönnerholm G, Rosenquist R, Sundström C. Thörn I, et al. Among authors: li a. Br J Haematol. 2011 Mar;152(6):743-53. doi: 10.1111/j.1365-2141.2010.08456.x. Epub 2011 Jan 20. Br J Haematol. 2011. PMID: 21250970 Free article.
Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01.
Zhou J, Goldwasser MA, Li A, Dahlberg SE, Neuberg D, Wang H, Dalton V, McBride KD, Sallan SE, Silverman LB, Gribben JG; Dana-Farber Cancer Institute ALL Consortium. Zhou J, et al. Among authors: li a. Blood. 2007 Sep 1;110(5):1607-11. doi: 10.1182/blood-2006-09-045369. Epub 2007 May 7. Blood. 2007. PMID: 17485550 Free PMC article. Clinical Trial.
Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection.
Li A, Zhou J, Zuckerman D, Rue M, Dalton V, Lyons C, Silverman LB, Sallan SE, Gribben JG. Li A, et al. Blood. 2003 Dec 15;102(13):4520-6. doi: 10.1182/blood-2003-05-1455. Epub 2003 Aug 28. Blood. 2003. PMID: 12946997 Free article.
14,153 results
You have reached the last available page of results. Please see the User Guide for more information.